Judith ?. Cook|Dennis D. Grey|Jane K. Burke-Miller|Mardge H. Cohen|David Vlahov|Farzana Kapadia|Tracey E. Wilson|Robert L. Cook|Rebecca Schwartz|Elizabeth T. Golub|Kathryn Anastos|Claudia Ponath|Lakshmi Goparaju|Alexandra M. Levine
Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women
University of Illinois at Chicago|University of Illinois at Chicago|University of Illinois at Chicago|John H. Stroger, Jr. Hospital of Cook County|New York Academy of Medicine|New York Academy of Medicine|SUNY Downstate Medical Center|State University of New York|University of Florida Health|SUNY Downstate Medical Center|State University of New York|Johns Hopkins University|Albert Einstein College of Medicine|University of California, San Francisco|Georgetown University Medical Center|Georgetown University|University of Southern California
examined interaction illicit drug use depressive symptoms affect subsequent likelihood highly active antiretroviral therapy haart use among women hivaidssubjects included 1710 hivpositive women recruited six sites us including brooklyn bronx chicago los angeles san franciscobay area washington dc cases probable depression identified using depressive symptom scores center epidemiologic studies depression scale crack cocaine heroin amphetamine use selfreported 6month time intervals conducted multivariate random logistic regression analysis data collected 16 waves semiannual interviews conducted april 1996 march 2004we found interaction effect illicit drug use depression acted suppress subsequent haart use controlling virologic immunologic indicators sociodemographic variables time study sitethis first study document interactive effects drug use depressive symptoms reduced likelihood haart use national cohort women since evidencebased behavioral health antiretroviral therapies three conditions available comprehensive hiv treatment achievable public health goal